Clinical Trials Logo

Filter by:
NCT ID: NCT06207682 Completed - Healthy Volunteers Clinical Trials

Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin

Start date: June 28, 2022
Phase: Phase 1
Study type: Interventional

The primary objective of this clinical study is to evaluate the effect of repeated oral doses of avacopan (30 mg and 60 mg twice daily approximately 12 hours apart [BID]) given under fed conditions on the PK of a single dose of simvastatin (40 mg) in healthy volunteers.

NCT ID: NCT06207435 Recruiting - Lung Cancer Clinical Trials

Community Support Program for Lung Cancer Screening

LCS
Start date: February 10, 2023
Phase: N/A
Study type: Interventional

The research study aims to create a program for lung cancer screening attendance

NCT ID: NCT06207409 Active, not recruiting - PTSD Clinical Trials

Program for Alleviating and Reducing Trauma, Stress, and Substance Use

(PARTS-SUD)
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

This single-arm study will test the preliminary efficacy of a virtually delivered, live-online 12-week group model of Internal Family Systems (IFS) for individuals with posttraumatic stress disorder (PTSD) and substance use disorders (Program for Alleviating and Reducing Trauma, Stress, and Substance Use, PARTS-SUD). Participants will be in a group for 12 weeks and will be asked to complete survey sessions at baseline and during week 4, 8 and 12.

NCT ID: NCT06207370 Recruiting - Babesiosis Clinical Trials

Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis

Start date: June 17, 2024
Phase: Phase 2
Study type: Interventional

This study is a double-blind, randomized, multisite, placebo-controlled trial comparing the safety and efficacy of TQ versus placebo in patients hospitalized for babesiosis with low risk for relapsing disease who will also be administered a standard-of-care antimicrobial regimen (A/A) that is recommended in the 2020 IDSA guideline on the diagnosis and management of babesiosis.

NCT ID: NCT06207318 Recruiting - Clinical trials for Coronary Artery Disease

Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery

ACT for CABG
Start date: February 12, 2024
Phase: N/A
Study type: Interventional

Heart disease is the leading cause of death globally, accounting for 16% of the world's total deaths. The number of cases is expected to increase as our population ages. Heart disease also results in large economic burden. It costs the United States about $219 billion per year. Some patients have symptoms that aren't helped by drugs or other medical treatments. These patients will need a surgery that is called cardiac artery bypass graft (CABG) surgery. CABG helps to improve chest pain which is one of the most common complaints of heart disease, and has life-prolonging potential. A limitation of CABG is that it results in increased inflammation. These patients also report high levels of anxiety and depression. Depression and anxiety in the several days surrounding surgery are related to several important things. These include worse health outcomes, worse quality of life, increased risk of death, and increased health care cost. Acceptance and Commitment Therapy (ACT) is a kind of therapy. ACT is adaptable, easy to access, and effective in brief formats. ACT has been gaining evidence for its use in many patient samples. Few studies have used ACT with heart disease patients. No known studies currently exist that have used ACT within the few days surrounding CABG surgery. To address this need, the investigators will conduct a two-arm feasibility randomized control trial (RCT). Patients will be randomized to one of two groups. The first group will complete a brief, 2-session telehealth ACT intervention. The second group will be a control group. The control will consist of treatment as usual. The investigators will evaluate the feasibility of this brief ACT intervention delivered in the peri-operative period. The investigators will also examine preliminary efficacy of the ACT intervention. The investigators will examine anxiety, depression, psychological inflexibility, well-being, and cardiovascular health-related quality of life. The investigators will also examine the intervention's impact on inflammation by measuring two inflammatory markers. The results from this study will also lay the groundwork for larger or multiple site RCT studies.

NCT ID: NCT06207305 Recruiting - Clinical trials for Intraperitoneal Paclitaxel

A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

Start date: January 30, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

To find the recommended dose of the drug paclitaxel that can be given intraperitoneally (given directly into the abdominal cavity) to participants with metastatic appendiceal adenocarcinoma.

NCT ID: NCT06207240 Completed - Stroke Clinical Trials

Functional Electrical Stimulation Therapy After Stroke

Start date: January 18, 2022
Phase: N/A
Study type: Interventional

The goal of this feasibility study is to test the feasibility of providing task-oriented, intention-driven functional electrical stimulation (FES) using the novel NeuroLife FES Sleeve and NeuroLife electromyography (EMG) and FES Sleeve devices in chronic stroke survivors. The main questions it aims to answer are: - Can these devices be used to administer task-oriented therapy with assistive stimulation at similar doses to current standards of care? - How does therapy using these devices impact the upper limb function in a few chronic stroke survivors? Participants will receive assistive electrical stimulation synchronized to their movement intention while practicing functional tasks with everyday objects over the course of 8 weeks.

NCT ID: NCT06207201 Recruiting - Cardiac Arrest Clinical Trials

Discover In-Hospital Cardiac Arrest

Discover IHCA
Start date: October 16, 2023
Phase:
Study type: Observational [Patient Registry]

The Discover In-Hospital Cardiac Arrest (IHCA) study is a multicenter, prospective observational study aimed at better understanding variations in practice for the post-in-hospital cardiac arrest patient.

NCT ID: NCT06207188 Recruiting - Clinical trials for Thyroid Gland Carcinoma

Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters

Start date: May 17, 2009
Phase:
Study type: Observational

This study is being done to identify and differentiate thyroid nodules by acoustic imaging and viscoelastic parameters.

NCT ID: NCT06207162 Not yet recruiting - Opioid Use Disorder Clinical Trials

Longitudinal Neural Fingerprinting of Opioid-use Trajectories

Start date: April 2024
Phase: N/A
Study type: Interventional

This project aims to collect a densely sampled neuroimaging dataset among individuals receiving medications for opioid use disorder (MOUD). MOUD is multiphasic, comprised of medication induction, stabilization, ongoing treatment, and eventual dis-continuation phases. However, with a few small exceptions, existing neuroimaging efforts are almost exclusively single time-point assessments which, by definition, fail to capture these clinically relevant transitions and thus also do not capture individual risk and resilience trajectories. The investigators innovation, the characterization of neurocomputational trajectories during clinically relevant phases of MOUD treatment, will provide unprecedented mechanistic insight into the neurobiological basis of recovery. Once characterized, such trajectories may be used in the identification of specific therapeutic windows for additional intervention (e.g., times of increased neural plasticity) and in the design of novel tailored interventions based on known brain mechanisms (e.g., behavioral therapy, neurostimulation, neurofeedback).